Lived experiences of treatment for hepatitis C in Australia

在澳大利亚治疗丙型肝炎的亲身经历

• 批准号: DP200100075
• 负责人: Prof Suzanne Fraser
• 金额: $ 24.82万
• 依托单位: La Trobe University
• 依托单位国家: 澳大利亚
• 项目类别: Discovery Projects
• 财政年份: 2020
• 资助国家: 澳大利亚
• 起止时间: 2020-09-01 至 2022-12-31
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/DP200100075
• 关键词: Lived; experiences; treatment; hepatitis; Australia

This project aims to support uptake of new hepatitis C treatments. With the introduction of new treatments in 2016, the Australian Government adopted the WHO’s goal of eliminating the disease by 2030. While early treatment rates were high, they have since plateaued, with stigma and poor information considered key obstacles. This project will generate new knowledge on treatment decisions and experiences, using a proven qualitative methodology. In doing so, it will produce a website covering personal experiences of treatment, issues in treatment decision-making, and advice on enhancing life on treatment and after. It will tackle hepatitis C-related stigma, and inform and benefit potential treatment users, families and relevant professionals.

该项目旨在支持采用新的丙型肝炎治疗方法。随着2016年新疗法的引入，澳大利亚政府采纳了世卫组织到2030年消除该疾病的目标。虽然早期治疗率很高，但此后一直停滞不前，耻辱感和信息匮乏被认为是主要障碍。该项目将使用经过验证的定性方法，产生有关治疗决策和经验的新知识。为此，它将制作一个网站，涵盖治疗的个人经历、治疗决策中的问题，以及改善治疗期间和治疗后生活的建议。它将解决与丙型肝炎相关的污名，并告知潜在的治疗使用者、家庭和相关专业人员并使其受益。